New High Sensitivity STD 12 Test

When vaginal discharge feels different from usual, it is not easy to distinguish which cases need treatment and which can be watched. In the clinic, even when the same test has been done, the reliability of the result differs depending on what method the test was done by. In this article, we look at the concepts of sensitivity and specificity, which frequently come up in sexually transmitted infection testing, and at how testing methods have advanced recently. It is a story focused not on which organisms are included in the test items, but on how accurately the test catches the organisms.

Even if the result sheet says positive or negative in a single line, there are many testing methods that produce that single line. In the past, culture tests or methods that capture antigens were often used, but even for the same organism, the rate of missing and the rate of falsely turning positive differ by test method.

This is exactly the point patients most often misunderstand in the clinic. It is not rare to see cases where the symptoms are clear yet a past test came back negative and was let go, and then a more precise test confirms the causative organism. A negative test does not always mean there is no organism, which means the accuracy of the test is that important.

So there are two yardsticks to look at when understanding a test. One is how well it finds people who are actually infected; the other is how well it sorts out people who are not infected as negative. These two are precisely sensitivity and specificity.

Sensitivity and specificity are the most basic indicators for evaluating the performance of a test. Knowing these two concepts lets you accept test results much more calmly.

• Sensitivity refers to the ability to accurately catch a person who is actually infected as positive. The higher the sensitivity, the fewer the false negatives that miss a true infection.
• Specificity refers to the ability to accurately sort out a person who is not infected as negative. The higher the specificity, the fewer the false positives that needlessly turn out positive.

According to the US Centers for Disease Control and Prevention (CDC)'s recommendations on sexually transmitted infection testing, a good test must keep both of these high. If only sensitivity is high and specificity is low, healthy people keep turning positive, which can lead to unnecessary treatment and anxiety; if only specificity is high and sensitivity is low, true infections are missed. In clinical experience, when I explain results to patients together with this balance, they tend to better understand why not everything is decided by a single test.

The key change that raised the accuracy of sexually transmitted infection testing is the introduction of nucleic acid amplification testing (NAAT). NAAT is a method that amplifies the genetic material of organisms to detect them, and its greatest strength, as reported, is that it can amplify the signal and catch organisms even when their numbers are very small.

The CDC presents NAAT as the recommended test method for chlamydia and gonorrhea testing (CDC, 2014·2021), and cites as the reason that it is generally superior to other test methods in sensitivity and specificity and that specimen transport is convenient. It is reported that even trace infections missed by past culture or antigen tests can be detected by NAAT.

However, NAAT is not all-powerful either. Even with the same NAAT, accuracy can differ depending on where the specimen was collected. For example, for some organisms, the detection rate is reported to be higher for specimens collected directly from the vagina or cervix than for urine specimens. So when getting tested, accuracy is guaranteed only when specimen collection appropriate to the symptoms and site is also carried out.

As testing methods have advanced, the information held by result sheets has also become richer. Whereas in the past it simply indicated presence or absence for 12 organisms, recently it is changing in the direction of providing more detailed information even within the same test.

Here, semi-quantitative means indicating in stages, beyond presence or absence, how relatively much is detected. It gauges the relative amount using the Ct value, which indicates the point at which the detection signal appears. Also, the internal control is a device that together confirms whether the entire process, from specimen collection to transport, extraction, and testing, was properly controlled, and it supports whether the test result itself is reliable. When information on the detected amount is added, it can help interpret the result together with symptoms, beyond simply whether it is positive.

If you are curious about discharge testing, feel free to inquire via chat

The fact that some organism was detected on a test does not mean that treatment is immediately needed. This is the part explained most carefully in the clinic.

For example, the CDC's 2021 sexually transmitted infection treatment guideline recommends, for Mycoplasma genitalium, not screening asymptomatic people and testing when symptoms persist or recur. It also recommends checking for drug resistance before treatment if this organism turns positive (CDC, 2021), because antibiotic resistance has been reported. It can be said that the more test accuracy rises, the more important the role of the medical staff in judging how to interpret the result and how far to treat actually becomes. If you are troubled by recurring chronic vaginitis, care that comprehensively examines the test results together with symptoms can help.

Test accuracy is not completed by a single piece of test equipment. The quality-control process that manages how specimens are handled and how results are verified actually underpins accuracy.

If the internal control mentioned earlier is a device that confirms the suitability of each individual specimen, a process of accumulating data by organism type to check the overall quality of testing is also carried out together. The point that indiscriminate testing in low-prevalence populations can increase false positives is also something the CDC points out, so judging whom to recommend which test to is likewise part of quality control.

In the clinic, accurate testing ultimately has meaning in that it lets patients avoid treatment they did not need to receive, and not miss treatment they must receive. The practical benefit of advances in testing methods to patients lies exactly at this point.

Symptoms such as changes in vaginal discharge, itching, odor, and pain are common, but the causes vary by organism, and tests and interpretations to match are needed. Both vaguely waiting despite having symptoms, and conversely repeating tests excessively when there are no symptoms, are not recommended directions.

If recurring vaginitis or abnormal discharge bothers you, it is good to receive both testing matched to the symptoms and interpretation of the results together. Since costs and test items can differ depending on symptoms, we provide guidance after a consultation. If you have questions related to women's disease treatment, you can hear a detailed explanation.

Written by: Lee Dong-hee Director · Obstetrics and Gynecology Specialist · See physician profile

First published March 21, 2024 · Last reviewed May 30, 2026

References: US Centers for Disease Control and Prevention Recommendations for Laboratory-Based Detection of Chlamydia and Gonorrhea (2014), US Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines (2021)

This article is intended to provide general health information and does not replace individual diagnosis or treatment. If you have symptoms, please consult through a medical visit.